We study genetic drivers, cancer metabolism, and therapeutics for cancer stem cells/brain tumors/#glioblastoma
@HarvardMed | @MGHNeurology | @MGH_RI
🇱🇧🇺🇸
Our new paper shows that targeting the enzyme SCD in breast cancer brain metastasis (BCBM) disrupts lipid metabolism and boosts anti-tumor immunity! This could pave the way for new therapies for this devastating disease. #BCBM#breastcancer https://t.co/S3iGwi85Hs
That was #EANO2024 – Congrats to Alessandro Sammarco for winning Best Poster Presentation in Glasgow! 🎉Research: Targeting SCD triggers lipotoxicity & enhances anti-tumor immunity in breast cancer brain metastasis models (Poster P04.03.A)
#NeuroOncology#CancerResearch#btsm
It was an honor to present our work on targeting lipid metabolism in #BrainTumors at #SNO2024. Deeply grateful to my lab members for their incredible hard work and talent. @MGH_RI @MGHNeurology @MGHNeuroOnc
👏Congratulations to our #EANO2024 award winners for Best Poster Presentation: Sophie Bockel (Clinical research), Alicia Buck (Basic research), Alessandro Sammarco (Translational research), Cressida Lorimer (Supportive care & quality of life research)! #NeuroOncology#btsm